Maynard Um
-
-
-
-
-
-
-
IDEAYA and Genentech to test drug combo in pancreatic cancer
-
-
-
-
-
-
-
Ideaya Biosciences (IDYA) Reiterated at Overweight by Cantor Fitzgerald
-
-
-
-
-
-
-
Ideaya Biosciences (IDYA) PT Raised to $40 at Oppenheimer
-
-
-
-
-
-
-
Mizuho on Ideaya Biosciences (IDYA): 'we recommend being opportunistic on weakness'
-
-
-
-
-
-
-
Ideaya Biosciences (IDYA) Reiterated at Market Outperform by Citizens: Shares Can Gain
-
-
-
-
-
-
-
Truist Securities Starts Ideaya Biosciences (IDYA) at Buy
-
-
-
-
-
-
-
Mizuho Reiterates Outperform Rating on Ideaya Biosciences (IDYA)
-
466,298 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


